PMID- 24579966 OWN - NLM STAT- MEDLINE DCOM- 20141027 LR - 20221207 IS - 1840-4812 (Electronic) IS - 1512-8601 (Print) IS - 1512-8601 (Linking) VI - 14 IP - 1 DP - 2014 Feb TI - An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus. PG - 21-4 AB - Studies that investigated an association between asymmetric dimethylarginine (ADMA) and glycated haemoglobin (HbA1c) in type 2 diabetes mellitus (T2DM) have given discordant results. The aim of this study was to determine and compare serum ADMA concentration in patients with T2DM and healthy controls, and to assess correlation between ADMA and HbA1c in patients with T2DM. Serum ADMA concentration was determined by ELISA method with the use of ADMA (R) - ELISA kit (DLD Diagnostics, Hamburg, Germany) and HbA1c levels were determined by an immunoturbidimetric method in 60 patients with T2DM and 60 healthy individuals matched for age and sex. Results have shown that mean serum ADMA concentration was significantly higher in T2DM patients (1.54+/-0.06 mumol/L) compared to mean serum ADMA concentration (0.62+/-0.02 mumol/L; p<0.0001) in healthy subjects. A significant, positive, correlation between serum ADMA concentration and HbA1c levels was observed (r=0.494; p<0.01) in T2DM patients. Our results suggest that there is an association between endothelial dysfunction and glycaemic control in type 2 diabetes mellitus. Possible explanation for obtained results may be oxidative stress that is increased in conditions of hyperglycaemia and it also promotes endothelial dysfunction. Larger, longitudinal studies are required that will evaluate relation between metabolic abnormalities and increased ADMA levels in patients with type 2 diabetes mellitus. FAU - Zaciragic, Asja AU - Zaciragic A AD - Department of Physiology, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71000 Sarajevo, Bosnia and Herzegovina. FAU - Huskic, Jasminko AU - Huskic J AD - Department of Physiology, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71000 Sarajevo, Bosnia and Herzegovina. FAU - Mulabegovic, Nedzad AU - Mulabegovic N AD - Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71000 Sarajevo, Bosnia and Herzegovina. FAU - Avdagic, Nesina AU - Avdagic N AD - Department of Physiology, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71000 Sarajevo, Bosnia and Herzegovina. FAU - Valjevac, Amina AU - Valjevac A AD - Department of Physiology, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71000 Sarajevo, Bosnia and Herzegovina. FAU - Hasic, Sabaheta AU - Hasic S AD - Department of Biochemistry, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71000 Sarajevo, Bosnia and Herzegovina. FAU - Jadric, Radivoj AU - Jadric R LA - eng PT - Journal Article PL - Bosnia and Herzegovina TA - Bosn J Basic Med Sci JT - Bosnian journal of basic medical sciences JID - 101200947 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 63CV1GEK3Y (N,N-dimethylarginine) RN - 94ZLA3W45F (Arginine) SB - IM MH - Arginine/*analogs & derivatives/blood MH - Blood Glucose/analysis MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*blood MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Glycated Hemoglobin/*analysis MH - Humans MH - Hyperglycemia/drug therapy MH - Male MH - Middle Aged MH - Nephelometry and Turbidimetry MH - Oxidative Stress PMC - PMC4333946 EDAT- 2014/03/04 06:00 MHDA- 2014/10/28 06:00 PMCR- 2014/02/01 CRDT- 2014/03/04 06:00 PHST- 2014/03/04 06:00 [entrez] PHST- 2014/03/04 06:00 [pubmed] PHST- 2014/10/28 06:00 [medline] PHST- 2014/02/01 00:00 [pmc-release] AID - BJBMS-14-21 [pii] AID - 10.17305/bjbms.2014.2291 [doi] PST - ppublish SO - Bosn J Basic Med Sci. 2014 Feb;14(1):21-4. doi: 10.17305/bjbms.2014.2291.